Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 3970605, 7 pages
https://doi.org/10.1155/2017/3970605
Research Article

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma

1Department of Thoracic Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
2Department of Gynecology and Obstetrics, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
3Department of General Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

Correspondence should be addressed to Junke Fu; moc.621@2166-knujuf

Received 1 August 2016; Accepted 22 November 2016; Published 11 January 2017

Academic Editor: Nejat K. Egilmez

Copyright © 2017 Haijun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H.-I. Kim, J.-H. Cheong, K. J. Song et al., “Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems,” Annals of Surgical Oncology, vol. 20, no. 8, pp. 2713–2720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Oda, S. Abe, C. Kusano et al., “Correlation between endoscopic macroscopic type and invasion depth for early esophagogastric junction adenocarcinomas,” Gastric Cancer, vol. 14, no. 1, pp. 22–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Matsuda, H. Takeuchi, S. Tsuwano et al., “Optimal surgical management for esophagogastric junction carcinoma,” General Thoracic and Cardiovascular Surgery, vol. 62, no. 9, pp. 560–566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Siewert and H. J. Stein, “Classification of adenocarcinoma of the oesophagogastric junction,” British Journal of Surgery, vol. 85, no. 11, pp. 1457–1459, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Vucenik and J. P. Stains, “Obesity and cancer risk: evidence, mechanisms, and recommendations,” Annals of the New York Academy of Sciences, vol. 1271, pp. 37–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Van Beijnum, P. T. M. Moerkerk, A. J. Gerbers et al., “Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer,” International Journal of Cancer, vol. 101, no. 2, pp. 118–127, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. A. K. Folgueira, D. M. Carraro, H. Brentani et al., “Gene expression profile associated with response to doxorubicin-based therapy in breast cancer,” Clinical Cancer Research, vol. 11, no. 20, pp. 7434–7443, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-Q. Bi, X.-M. Che, X.-H. Liao et al., “Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil,” Oncology Reports, vol. 26, no. 5, pp. 1251–1257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Flegal, D. Kruszon-Moran, M. D. Carroll, C. D. Fryar, and C. L. Ogden, “Trends in obesity among adults in the United States, 2005 to 2014,” The Journal of the American Medical Association, vol. 315, no. 21, pp. 2284–2291, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Turati, I. Tramacere, C. La Vecchia, and E. Negri, “A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma,” Annals of Oncology, vol. 24, no. 3, pp. 609–617, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Gucalp, N. M. Iyengar, C. A. Hudis, and A. J. Dannenberg, “Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression,” Seminars in Oncology, vol. 43, no. 1, pp. 154–160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. Mcniece, “Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor,” Molecular and Cellular Biology, vol. 14, no. 2, pp. 1431–1437, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Sun, L. Li, R. Li et al., “Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats,” Annals of Medicine, vol. 41, no. 4, pp. 311–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. Grolla, C. Travelli, A. A. Genazzani, and J. K. Sethi, “Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine,” British Journal of Pharmacology, vol. 173, no. 14, pp. 2182–2194, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Revollo, A. A. Grimm, and S.-I. Imai, “The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals,” Current Opinion in Gastroenterology, vol. 23, no. 2, pp. 164–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Garten, S. Petzold, A. Körner, S.-I. Imai, and W. Kiess, “Nampt: linking NAD biology, metabolism and cancer,” Trends in Endocrinology & Metabolism, vol. 20, no. 3, pp. 130–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Beddy, J. Howard, C. McMahon et al., “Association of visceral adiposity with oesophageal and junctional adenocarcinomas,” British Journal of Surgery, vol. 97, no. 7, pp. 1028–1034, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Donohoe, S. L. Doyle, S. McGarrigle et al., “Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma,” British Journal of Surgery, vol. 99, no. 3, pp. 387–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-J. Li, X.-M. Che, W. Zhao, S.-C. He, Z.-L. Zhang, and R. Chen, “Diet-induced obesity potentiates the growth of gastric cancer in mice,” Experimental and Therapeutic Medicine, vol. 4, no. 4, pp. 615–620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. C. Gusky, J. Diedrich, O. A. Macdougald, and I. Podgorski, “Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression,” Obesity Reviews, vol. 17, no. 11, pp. 1015–1029, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. K. M. Nieman, I. L. Romero, B. Van Houten, and E. Lengyel, “Adipose tissue and adipocytes support tumorigenesis and metastasis,” Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, vol. 1831, no. 10, pp. 1533–1541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Deng, C. J. Lyon, S. Bergin, M. A. Caligiuri, and W. A. Hsueh, “Obesity, inflammation, and cancer,” Annual Review of Pathology: Mechanisms of Disease, vol. 11, pp. 421–449, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-R. Kim, H.-J. Park, Y.-H. Bae et al., “Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion,” Endocrinology, vol. 153, no. 2, pp. 554–563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. G. Kim, E. O. Kim, B. R. Jeong et al., “Visfatin stimulates proliferation of MCF-7 human breast cancer cells,” Molecules and Cells, vol. 30, no. 4, pp. 341–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. T. Patel, T. Mistry, J. E. P. Brown et al., “A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis,” Peptides, vol. 31, no. 1, pp. 51–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. S. Reddy, S. Umesh, B. Thota et al., “PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value,” Cancer Biology and Therapy, vol. 7, no. 5, pp. 663–668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. E. Nakajima, Y. Yamada, T. Hamano et al., “Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer,” Journal of Gastroenterology, vol. 44, no. 7, pp. 685–690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. E. Nakajima, Y. Yamada, T. Hamano et al., “Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer,” Cancer Science, vol. 101, no. 5, pp. 1286–1291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Yakar, N. P. Nunez, P. Pennisi et al., “Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones,” Endocrinology, vol. 147, no. 12, pp. 5826–5834, 2006. View at Publisher · View at Google Scholar · View at Scopus